Consultant, Medical Oncology, Tata Memorial Hospital, Mumbai, India; Chair Professor (CoE), Cancer Research in Genetics, Maharashtra University of Health Sciences (MUHS), Maharashtra, India
In addition to the content from our 2023 speakers featured below, access dozens of on-demand presentations from past OncomineWorld meetings, too!
Consultant, Medical Oncology, Tata Memorial Hospital, Mumbai, India; Chair Professor (CoE), Cancer Research in Genetics, Maharashtra University of Health Sciences (MUHS), Maharashtra, India
Head of Molecular Pathology Department, Humanitas Research Hospital, Italy
Associate Professor, Edith Cowan University, Australia
Professor of Pathology and Head of Laboratory of Clinical and Experimental Pathology at Louis Pasteur Hospital, Nice, France
Director of Comprehensive Breast Health Center, Taipei Veterans General Hospital, Taiwan
Director, Instruments, Thermo Fisher Scientific
Department of Pathology, University Hospital October 12, Madrid, Spain
Clinical Director, Haemato-oncology Diagnostic Service (HODS) Cheshire & Merseyside Cancer Network, Liverpool Clinical Laboratories, United Kingdom
Chief Development Officer, NYS CLEP Laboratory Director, Biodesix Inc., Louisville, CO
Vice President and Global Head of Medical Affairs, Thermo Fisher Scientific
Associate Director for the Center of Integrated Diagnostics, Massachusetts General Hospital, Boston, Massachusetts, Assistant Professor of Pathology, Harvard Medical School
Professor, Research Chair, and Program Head, Western University and London Health Sciences, Ontario, Canada
Head of Gynecological Pathology and Mammary Pathology Division, University Hospital Tuebingen, Germany
Director of Molecular Pathology, Cedars-Sinai Medical Center, Los Angeles, California
Senior Hospital Scientist, SydPath - St. Vincent's Hospital, Sydney, Australia
Lead, Haemato-oncology Diagnostic Service (HODS) Cheshire & Merseyside Cancer Network, Liverpool Clinical Laboratories, United Kingdom
Sr. Product Manager, Oncology, Thermo Fisher Scientific
The premier event in NGS education is now available on demand. Since 2020, OncomineWorld meetings have brought together thousands of scientists and professionals from around the world each year to advance genomic profiling in clinical oncology research.
OncomineWorld 2023 features brand new presentations from leading international researchers as they share their experiences in rapid lung next-generation sequencing, hemato-oncology research, the assessment of homologous recombination repair deficiency (HRD), and more. Hear from our Oncomine Clinical Research Grant awardees who have received instrumentation and funding from Thermo Fisher Scientific to study high-impact applications of next-generation sequencing in clinical oncology.
In addition to new on-demand presentations, here are some additional event features you can look forward to exploring:
Earn Continuing Education (CE) credits as you:
We hope you enjoy visiting OncomineWorld 2023 on-demand!
In addition to the content from our 2023 speakers featured below, access dozens of on-demand presentations from past OncomineWorld meetings, too!
In addition to the content from our 2023 speakers featured below, access dozens of on-demand presentations from past OncomineWorld meetings, too!
Earn Continuing Education (CE) credits from OncomineWorld presentations! Attend a live or on demand session to obtain your credits.
The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here.